Early Access

10-QPeriod: Q3 FY1994

BRISTOL MYERS SQUIBB CO Quarterly Report for Q3 Ended Sep 30, 1994

Filed November 14, 1994For Securities:BMYCELG-RIBMYMP

Summary

Bristol Myers Squibb Company's (BMY) 10-Q filing for the period ending September 29, 1994, indicates a company in the midst of its fiscal third quarter. While the provided text is primarily navigational and descriptive of SEC filing system elements rather than direct financial data, it signifies the company's regular reporting cadence. Investors would typically look to the financial statements within such a filing for revenue trends, profitability, cash flow generation, and any significant changes in assets, liabilities, or equity. The existence of this filing confirms BMY's commitment to transparency and ongoing disclosure to the market, allowing stakeholders to assess the company's performance and financial health.

Key Highlights

  • 1BMY filed its 10-Q report for the period ending September 29, 1994.
  • 2The filing date was November 13, 1994, indicating timely reporting.
  • 3This report is a standard quarterly filing, crucial for tracking ongoing business performance.
  • 4The filing confirms BMY's adherence to SEC disclosure requirements.
  • 5Investors can use this report to assess the company's financial standing and operational progress during the third quarter of 1994.
  • 6The structure of the filing suggests that detailed financial data and management discussion would be contained within the linked documents, not the provided navigational text.

Frequently Asked Questions